BG
BTX.WS

Bellevue Group’s BioTime Inc Warrants (Expiring October 1, 2018) BTX.WS Stock Holding History

Bellevue Group’s Portfolio BTX.WS Stock Details BTX.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-2,294
Closed -$1K – 137
2016
Q1 		$1K Buy
+2,294
New +$1.55K ﹤0.01% 130

Other funds holding BTX.WS

ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D Trenton, New Jersey $25.9B AUM 26.38% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bellevue Group's BTX.WS Position: Q2 2016 in Review

Bellevue Group sold out of BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) in Q2 2016, closing a stake of 2,294 shares — an estimated $1K sold.

Bellevue Group first reported a position in BTX.WS in Q1 2016 and held it in 1 quarter. The position peaked at $1K in Q1 2016. 38 funds tracked by Wall St. Rank hold BTX.WS as of Q2 2016.

  • Bellevue Group reported no remaining BioTime Inc Warrants (Expiring October 1, 2018) position as of Q2 2016 after selling out during the quarter.
  • Bellevue Group sold 2,294 BioTime Inc Warrants (Expiring October 1, 2018) shares in Q2 2016, an estimated $1K.
  • Bellevue Group first reported a position in BioTime Inc Warrants (Expiring October 1, 2018) in Q1 2016 and held it in 1 quarter.
  • Bellevue Group's BioTime Inc Warrants (Expiring October 1, 2018) position peaked at $1K in Q1 2016.
  • 38 funds tracked by Wall St. Rank held BioTime Inc Warrants (Expiring October 1, 2018) as of Q2 2016.

Based on Bellevue Group's 13F filing for Q2 2016, filed 12 Aug 2016.